Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ISRCTN |
Last refreshed on:
|
6 June 2022 |
Main ID: |
ISRCTN61225414 |
Date of registration:
|
29/12/2015 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
E-Freeze: Freezing of embryos in assisted conception
|
Scientific title:
|
Freezing of embryos in assisted conception: a randomised controlled trial evaluating the clinical and cost-effectiveness of a policy of freezing embryos followed by thawed frozen embryo transfer, compared with a policy of fresh embryo transfer in women undergoing in-vitro fertilization. |
Date of first enrolment:
|
01/01/2016 |
Target sample size:
|
1086 |
Recruitment status: |
Completed |
URL:
|
https://www.isrctn.com/ISRCTN61225414 |
Study type:
|
Interventional |
Study design:
|
Pragmatic multi-centre parallel-group randomised controlled trial (Other)
|
Phase:
|
Not Applicable
|
|
Countries of recruitment
|
England
|
Scotland
|
United Kingdom
| | | | | |
Contacts
|
Name:
|
Christina
Cole |
Address:
|
NPEU
Nuffield Department of Population Health
University of Oxford
Old Road Campus
OX3 7LF
Oxford
United Kingdom |
Telephone:
|
- |
Email:
|
christina.cole@npeu.ox.ac.uk |
Affiliation:
|
|
|
Name:
|
Abha
Maheshwari |
Address:
|
Aberdeen Maternity Hospital
Foresterhill
AB25 2ZL
Aberdeen
United Kingdom |
Telephone:
|
|
Email:
|
|
Affiliation:
|
|
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: Current participant inclusion criteria (as of 24/01/2018): 1. The female partner is between 18 and 42 years of age at the start of treatment (i.e. start of ovarian stimulation) 2. Couples who are undergoing their first second or third cycle of IVF/ICSI treatment 3. Both partners are resident in the UK 4. Both partners are able to provide written informed consent
Previous participant inclusion criteria 1. The female partner is between 18 and 42 years of age at the start of treatment (i.e. start of ovarian stimulation) 2. Couples who are undergoing their first cycle of IVF/ICSI treatment 3. Both partners are resident in the UK 4. Both partners are able to provide written informed consent
Exclusion criteria: Couples in whom: 1. Donor gametes are used 2. Pre-implantation genetic diagnosis is performed 3. Elective freezing of all embryos is preferred or clinically indicated (e.g. severe risk of OHSS)
Age minimum:
Age maximum:
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Infertility Pregnancy and Childbirth Infertility
|
Intervention(s)
|
Couples will be randomly allocated to either the standard care or intervention arm.
Standard care arm: Women will undergo fresh embryo transfer on day 3 or 5 (after egg collection).
Intervention arm: All good quality embryos will be frozen and couples will undergo frozen thawed embryo transfer within 3 months of the egg collection process. Couples will attend for a clinic visit and additional monitoring visits before frozen embryo transfer is performed.
Data be collected using bespoke electronic data collection forms at 6 time points between consent and 6 weeks post delivery. An emotions questionnaire will also be completed both after consent and at embryo transfer to understand how couples are feeling. And an economic questionnaire will be used to understand time and travel expenses accrued during their treatment.
|
Primary Outcome(s)
|
Health of the baby is determined by medical staff at the time of birth.
|
Secondary Outcome(s)
|
1. Live birth rate 2. Pregnancy rate (defined as positive pregnancy test - 2 weeks after embryo transfer) 3. Clinical pregnancy rate (a pregnancy diagnosed by ultrasonic visualisation of one or more gestational sacs or definitive clinical signs of pregnancy; ectopic counts as clinical pregnancy; multiple gestational sacs count as one clinical pregnancy) 4. Ongoing pregnancy (pregnancy with presence of foetal heart beat) 5. Ovarian hyperstimulation syndrome (OHSS) 6. Miscarriage rate 7. Gestational diabetes mellitus (GDM) 8. Multiple pregnancy 9. Hypertensive disorders of pregnancy (comprising pregnancy induced hypertension; pre-eclampsia and eclampsia) 10. Antepartum haemorrhage 11. Preterm delivery (defined as delivery at <37 completed weeks) 12. Very preterm delivery (defined as delivery at <32 completed weeks) 13. Low birth weight (defined as weight < 2500 g at birth) 14. Very low birth weight (defined as < 1500 g at birth) 15. Large for gestational age (defined as birth weight >90th centile for gestation, based on standardised charts) 16. Small for gestational age (defined as less than 10th centile for gestational age at delivery) 17. Congenital anomaly (all congenital anomalies identified will be included) 18. Perinatal mortality (late as well as early neonatal deaths, up to 28 days after birth) 19. Evaluation of emotional state 20. Health economic outcome measures: 20.1. Costs to the health service of treatment, pregnancy and delivery care 20.2. Modelled long-term costs of health and social care, and broader societal costs
|
Source(s) of Monetary Support
|
National Institute for Health Research
|
Ethics review
|
Status:
Approval date:
Contact:
North of Scotland Research Ethics Committee, 12/11/2015, ref: 15/NS/0114
|
Results
|
Results available:
|
Yes |
Date Posted:
|
|
Date Completed:
|
31/01/2021 |
URL:
|
|
|
|